Ranjit Kumar Goudar
Affiliation: Duke University Medical Center
- New therapeutic options for mesotheliomaRanjit Kumar Goudar
Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
Curr Oncol Rep 7:260-5. 2005....
- Hypoxia, angiogenesis, and lung cancerRanjit K Goudar
Department of Medicine, Duke University Medical Center, Box 3841, Durham, NC 27710, USA
Curr Oncol Rep 10:277-82. 2008..Combinations of antiangiogenic drugs and conventional cytotoxic chemotherapy are currently under development...
- Management options for malignant pleural mesothelioma: clinical and cost considerationsRanjit K Goudar
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27701, USA
Drugs 67:1149-65. 2007..MPM treatment is a costly public health issue; after efficacy is proven, additional studies are needed to measure the cost effectiveness of MPM treatment regimens...
- Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition)Momen M Wahidi
Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Box 3683, Durham, NC 27710, USA
Chest 132:94S-107S. 2007..The solitary pulmonary nodule (SPN) is a frequent incidental finding that may represent primary lung cancer or other malignant or benign lesions. The optimal management of the SPN remains unclear...